LifeSci Acquisition – a so-called ‘blank cheque’ company – has announced a $60 million merger with Vincera Pharma that will focus on developing cancer drugs.
“The days of the blank-cheque consulting projects, where they just threw money at everything, are really a thing of the past now,” said Dane Albertelli, senior research analyst at Source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback